Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Net Income towards Common Stockholders (2016 - 2026)

Nutex Health (NUTX) has disclosed Net Income towards Common Stockholders for 15 consecutive years, with $62.8 million as the latest value for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders rose 319.45% year-over-year to $62.8 million; the TTM value through Mar 2026 reached $192.3 million, up 73.48%, while the annual FY2025 figure was $180.4 million, 245.65% up from the prior year.
  • Net Income towards Common Stockholders hit $62.8 million in Q1 2026 for Nutex Health, up from $16.6 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $100.0 million in Q4 2024 and bottomed at -$422.5 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$9.7 million, with a median of $3.0 million recorded in 2024.
  • Year-over-year, Net Income towards Common Stockholders tumbled 885.45% in 2022 and then skyrocketed 4210.71% in 2025.
  • Nutex Health's Net Income towards Common Stockholders stood at $9.9 million in 2022, then tumbled by 379.08% to -$27.7 million in 2023, then skyrocketed by 461.03% to $100.0 million in 2024, then plummeted by 83.4% to $16.6 million in 2025, then soared by 277.91% to $62.8 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $62.8 million, $16.6 million, and $96.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.